KRBL Limited (KRBL) Q3 22/23 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 22/23 earnings summary
22 Oct, 2026Executive summary
Q3 FY23 revenue from operations rose 33% YoY to Rs 1,53,599 lakh; PAT reached Rs 20,545 lakh, up from Rs 7,336 lakh.
Growth was supported by higher realizations, stronger domestic and export sales, and procurement 47% above the prior year to meet orders and aging needs.
Financial highlights
Q3 total income was Rs 1,55,393 lakh versus Rs 1,16,868 lakh; EBITDA was Rs 297 crore and PAT was Rs 205 crore.
Gross profit rose 82% YoY; gross margin was 29.3%, up 800 bps YoY but down from 34.6% in Q2, reflecting product mix and higher input costs.
EBITDA margin was 19.1%; PBT and PAT margins improved to 17.7% and 13.2% from 8.6% and 6.3% a year earlier.
9M FY23 revenue from operations reached Rs 4,08,350 lakh and PAT Rs 58,300 lakh, up 66% YoY; EBITDA rose 57.6% to Rs 844 crore.
Outlook and guidance
Q4 realizations and shipment volumes were expected to reflect higher prices, with Ramadan-related demand effects in the quarter.
Export Basmati prices were viewed as sustainable over the long run, though management expected volatility with importer demand.
HoReCa target share rose to 20%-25% from ~10%, with a goal to double segment revenue within two years.
Pesticide-resistant Basmati varieties were expected in limited quantities in 2023 and sufficient quantities for the 2024 crop, supporting plans to enter Europe and the U.S.
Latest events from KRBL Limited
- Independent review launched after director’s resignation; export receivable write-off detailed.KRBL
Investor update - Record Q1 profit and domestic growth; unresolved ED investigation qualified the audit.KRBL
Q1 22/23 - Record Q2 results and surging exports, with higher procurement plans and unresolved ED matters.KRBL
Q2 22/23 - Record FY23 earnings, but Q4 margin pressure, ED uncertainty and negative operating cash flow persisted.KRBL
Q4 22/23 - Domestic growth offset export weakness as input costs pressured profits and the ED review remained qualified.KRBL
Q2 23/24 - Record Q3 revenue was export-led as the ED matter remained an audit qualification.KRBL
Q3 24/25 - Domestic growth was offset by export weakness, margin pressure and ED-related uncertainty.KRBL
Q3 23/24 - Q1 PAT rose sharply as exports surged, while ED proceedings remain an audit qualification.KRBL
Q1 25/26 - Record Q1 profitability despite export disruption; the ED matter qualified the review.KRBL
Q1 26/27